| Course | N599 Nursing Capstone |
|---|---|
| Module | Module 1 |
| Paper type | Capstone problem statement |
| Length | About 1,126 words, 7 pages |
| Format | APA 7 student paper |
| School | Aspen University |
| Program | MSN |
| Updated | September 2026 |
Free sample paper for N599 Module 1
Finishing What We Start: The Problem of Incomplete Latent Tuberculosis Treatment at a County Clinic and a Capstone Project Question
Student Name
Master of Science in Nursing Program, Aspen University
N599: Nursing Capstone
Instructor Name
Month Day, Year
Finishing What We Start: The Problem of Incomplete Latent Tuberculosis Treatment at a County Clinic and a Capstone Project Question
A composite county health department in a mid-sized city runs a tuberculosis clinic that diagnoses and treats latent tuberculosis infection, the dormant form of infection that causes no symptoms and is not contagious but can progress to active, transmissible disease. Most of the clinic's patients were born in countries where tuberculosis is common, and many are recently resettled refugees, students or workers holding more than one job. Over the past twelve months, 164 patients started treatment for latent infection, most of them on four months of daily rifampin taken at home. Only 95 of them, 58%, completed treatment. The other 69 patients remain at risk of developing active tuberculosis, and every case that develops will mean illness for the patient, a contact investigation for the clinic and possible transmission to family and coworkers.
This paper defines the problem that the capstone project will address, places it in the context of tuberculosis prevention in the United States, explains why the clinic's current approach produces incomplete treatment, and states the project question that the remaining sections of the capstone will answer.
Background and Significance
Treating latent tuberculosis infection is central to eliminating tuberculosis in the United States, because most new cases arise from reactivation of infection acquired years earlier rather than from recent transmission. Treatment works: shorter regimens containing rifamycins are now preferred because they are as effective as older regimens and more likely to be completed. National guidelines now recommend three rifamycin-based regimens, a dozen weekly doses of rifapentine combined with isoniazid, four months of daily rifampin, and three months of daily isoniazid and rifampin, over the longer isoniazid-only regimens (Sterling et al., 2020).
Completion, however, is where many patients fall away. Pooling 58 studies that together followed more than 748,000 people, one systematic review found large losses at several steps between screening and cure, including completion of treatment among those who start it (Alsdurf et al., 2016). A patient who does not complete treatment receives little protection, while the health system has spent the effort of testing, evaluation and prescribing. Improving completion is therefore one of the most efficient ways a clinic can prevent future cases.
Why Patients at This Clinic Do Not Finish
A review of the 69 incomplete courses, together with interviews with the clinic's two public health nurses and outreach worker, points to four contributing factors. First, daily medication for four months is a heavy burden for patients who feel well and do not see a benefit, and missed doses accumulate quietly. Second, the clinic's follow-up relies on monthly in-person visits that patients working hourly jobs struggle to attend; most incomplete courses ended after a missed monthly visit. Third, contact between visits is limited to phone calls from a single outreach worker, often unanswered. Fourth, even with interpreters, language barriers make it hard to explain why a person without symptoms should take pills for months.
The factors suggest two levers. A shorter regimen with weekly rather than daily dosing reduces the burden, and a way of observing doses that does not require travel could maintain contact without clinic visits.
The timing of dropout matters as much as its causes. Of the 69 incomplete courses, 41 ended within the first six weeks, most often in the gap between the first and second monthly visits, when the patient had no contact with the clinic for a month and side effects, such as nausea or orange-colored urine, were still unfamiliar. A further 17 ended in the second or third month after a missed visit, and 11 ended because the patient moved or could no longer be reached. The pattern suggests that the first weeks of treatment, not the last, are where an intervention can do the most good, and that contact in those weeks should be frequent and easy for the patient.
Evidence Pointing to a Solution
Both levers have support. Sterling et al. (2011) randomized adults to the dozen supervised weekly doses or to nine months of daily isoniazid; the short course prevented tuberculosis no less well, and 82.1% of its patients finished, against 69.0%. For observation, smartphone video-observed therapy allows patients to record themselves taking each dose and send the video to a nurse. In a randomized trial among patients with active tuberculosis, many with complex social needs, Story et al. (2019) found that seven in ten patients on video observation had four in five of their early doses seen, compared with about three in ten watched in person. Neither study was conducted in a clinic like this one, and the second concerned active rather than latent disease, but together they suggest that a weekly regimen observed by video could fit the lives of the clinic's patients.
The Project Question
The capstone project will implement and evaluate a nurse-led change in the clinic's standard approach. The project question, in PICOT form, is: among adults starting treatment for latent tuberculosis infection at the county clinic (P), does a three-month course of weekly rifapentine plus isoniazid, with a nurse watching a phone video of every dose (I), compared with four months of daily rifampin taken at home and checked at monthly appointments (C), increase the proportion of patients who complete treatment (O) during a six-month implementation period (T)?
This is quality improvement work, not a research study: it applies an evidence-based change to local practice and measures its effect, using the clinic's own records. Secondary questions concern which patients choose video observation, how many weekly videos are missed and why, and how much nursing time the approach requires. Patients who prefer daily rifampin, or who have contraindications to rifapentine, will continue to receive it with improved follow-up.
Success will be judged against a target set with the clinic's nurses and medical director before implementation begins: overall completion of at least 75% during the six months, a gain of about 17 percentage points over the baseline. The target is ambitious but realistic in light of completion rates reported in trials and cohort studies of the weekly regimen, and setting it in advance prevents the team from redefining success after seeing the results.
Conclusion
Incomplete treatment of latent tuberculosis infection at the county clinic leaves nearly half of treated patients unprotected and wastes much of the effort that brought them into care. Local review suggests that daily dosing and monthly travel are central barriers, and the evidence suggests that a weekly regimen observed by video could reduce both. The capstone project will test that approach in the clinic's own population, asking whether it increases treatment completion. The sections that follow review the literature, set out a guiding framework, describe the project's design, and report and discuss its results.
References
Alsdurf, H., Hill, P. C., Matteelli, A., Getahun, H., & Menzies, D. (2016). The cascade of care in diagnosis and treatment of latent tuberculosis infection: A systematic review and meta-analysis. The Lancet Infectious Diseases, 16(11), 1269-1278. https://doi.org/10.1016/S1473-3099(16)30216-X
Sterling, T. R., Njie, G., Zenner, D., Cohn, D. L., Reves, R., Ahmed, A., Menzies, D., Horsburgh, C. R., Crane, C. M., Burgos, M., LoBue, P., Winston, C. A., & Belknap, R. (2020). Guidelines for the treatment of latent tuberculosis infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020. MMWR Recommendations and Reports, 69(1), 1-11. https://doi.org/10.15585/mmwr.rr6901a1
Sterling, T. R., Villarino, M. E., Borisov, A. S., Shang, N., Gordin, F., Bliven-Sizemore, E., Hackman, J., Hamilton, C. D., Menzies, D., Kerrigan, A., Weis, S. E., Weiner, M., Wing, D., Conde, M. B., Bozeman, L., Horsburgh, C. R., & Chaisson, R. E. (2011). Three months of rifapentine and isoniazid for latent tuberculosis infection. New England Journal of Medicine, 365(23), 2155-2166. https://doi.org/10.1056/NEJMoa1104875
Story, A., Aldridge, R. W., Smith, C. M., Garber, E., Hall, J., Ferenando, G., Possas, L., Hemming, S., Wurie, F., Luchenski, S., Abubakar, I., McHugh, T. D., White, P. J., Watson, J. M., Lipman, M., Garfein, R., & Hayward, A. C. (2019). Smartphone-enabled video-observed versus directly observed treatment for tuberculosis: A multicentre, analyst-blinded, randomised, controlled superiority trial. The Lancet, 393(10177), 1216-1224. https://doi.org/10.1016/S0140-6736(18)32993-3
N599 Module 1 instructions, in plain terms
The first work in Aspen's MSN capstone is typically a problem statement and project question built from a real gap in your practice setting. Describe the setting and the problem with local numbers. Explain the problem's significance with current guidelines and research. Analyze why it happens, using chart review, interviews or other local data. Identify what could be changed. Present evidence that points toward a solution. Frame a narrow project question and label the work as either quality improvement or research. Pick a problem small enough to finish inside the capstone, because the literature review, methods and final report all build on this choice.
Inside the N599 Module 1 example
The introduction describes the county clinic and the infection it treats, then states the completion problem. The background section explains that most new tuberculosis cases in the United States come from reactivation of old infection, so treating latent infection prevents future disease, and summarizes the cascade of losses from testing to completion. The local analysis section reviews the 69 courses that were not finished and reports four factors from charts and interviews, such as long regimens, monthly visits that conflict with work and language barriers, then groups them into two levers: regimen length and contact with nurses. The evidence section shows support for both levers. The question section asks whether a nurse-led change raises completion and labels the work quality improvement. The conclusion restates the cost of incomplete treatment.
Where the marks sit in the N599 Module 1 rubric
Capstone problem statements in N599 gain marks for a clear, local problem, documented significance, analysis of causes, evidence pointing to change and a precise question. Local numbers make the problem real. National guidelines and a cascade review show why it matters beyond one clinic. The chart review and interviews reveal causes rather than assuming them. The question is answerable within the project's scope and correctly labeled as improvement work. Alsdurf's 2016 Lancet Infectious Diseases review of the cascade of care and Sterling's 2020 MMWR guidelines for treating latent infection anchor the paper in APA 7. The two levers, regimen length and nurse contact, set up the literature review that follows.
Common N599 Module 1 mistakes, and how to avoid them
Another weak spot is a problem stated only in national figures, with nothing from the unit itself. Bring the problem to your setting with numbers. Another gap is jumping to a solution before analyzing causes. Review charts or interview staff first. Questions are often sized for a career, not a single term. Narrow the population, intervention and outcome. Label the project correctly as quality improvement or research, since that affects approvals. Keep the clinic composite. Cite current guidelines, which change. Avoid blaming patients for not finishing; describe barriers. Finally, check that the data you will need later can actually be collected, since a question without data cannot be answered in Module 5.
Write yours, or have the desk draft it
This paper is an original model document written by our desk, not a submitted student paper and not an official Aspen University document. Read it for the moves, then write your own to the instructions in your classroom. If you want one built to your exact prompt and rubric, the first custom sample is free and arrives in 24 to 48 hours.
More N599 and MSN sample papers
- N599 Module 2: Capstone Literature Review
- N599 Module 3: Capstone Theoretical Framework
- N599 Module 4: Capstone Design and Methods
- N599 Module 5: Capstone Results
- N599 Module 6: Capstone Discussion
- N599 Module 7: Capstone Dissemination
- N599 Module 8: Final Capstone Paper
- N512 Module 2: Cultural Theories and Models
- N522 Module 2: Organizational Structure Analysis
- N682 Module 6: Adolescent Suicide Risk
- N684 Module 7: Caseload and Acuity Leadership
N599 Module 1 questions, answered
What does N599 Module 1 usually ask for?
The first work in Aspen's MSN capstone is typically a problem statement and project question for the student's original applied project, built on data from practice. Check your classroom and capstone guide for the exact requirements.
Is a capstone project the same as research?
Usually not. Most MSN capstones are applied or quality improvement projects that implement evidence in a local setting and measure the effect, rather than studies designed to produce generalizable knowledge.
What makes a strong capstone question?
A specific population, intervention, comparison, outcome and time frame, framed so the answer would change local practice and can be measured with data the student can actually obtain.
Where can I find a free N599 Module 1 sample paper?
The full N599 Module 1 problem statement is above, describing incomplete latent tuberculosis treatment at a county clinic and a nurse-led project question.
Why treat latent tuberculosis in N599 Module 1?
Most new tuberculosis cases in the United States come from reactivation of old infection, so completing treatment for latent infection prevents future disease.